
Karin & Coert. Personally involved.

years in pharma,
consumer health & strategy
product & market
introductions guided
countries under commercial
strategy responsibility
International experience.
Local understanding.
Whether you want to grow, attract funding or find a partner, we help you work out the best route—and take it forward.
Growth, investment or a strategic partner: each needs a clear commercial direction, a credible case and the right people involved.
Grow the business.
We help you decide which customers and markets to focus on, why they would choose your innovation and how your team can turn that opportunity into business.
Get ready for investors.
We help you build a clear business case, with realistic financials and a convincing explanation of what the investment will make possible.
Find the right partner or buyer.
We help you identify suitable partners or buyers, explain why your innovation matters to them and bring the right people into the conversation.
Biotech · Medtech · Diagnostics · Pharma · Consumer health
Biotech · Medtech · Diagnostics · Pharma · Consumer health
We build on what you already have, strengthen what is missing and agree which conversations make sense now. Preparation and relevant market feedback can move together.
We build on what you already have, strengthen what is missing and agree which conversations make sense now. Preparation and relevant market feedback can move together.
Commercial strategy, positioning, business model, market-entry choices and financial assumptions. For growth assignments: priority opportunities, team roles, a 90-day action plan and a 12-month roadmap.
Business plan, financial model, valuation rationale, investor deck, teaser and partner or customer presentations. Data-room priorities, Q&A and preparation for important conversations.
Candidate selection, target mapping, tailored approaches, selected introductions, meeting preparation and follow-up. Transaction and due-diligence support within an agreed scope, alongside specialists where needed.
Commercial strategy, positioning, business model, market-entry choices and financial assumptions. For growth assignments: priority opportunities, team roles, a 90-day action plan and a 12-month roadmap.
Business plan, financial model, valuation rationale, investor deck, teaser and partner or customer presentations. Data-room priorities, Q&A and preparation for important conversations.
Candidate selection, target mapping, tailored approaches, selected introductions, meeting preparation and follow-up. Transaction and due-diligence support within an agreed scope, alongside specialists where needed.
When needed, we collaborate with trusted transaction and legal specialists to support formal deal execution.
A focused project or ongoing senior support. We agree the scope, priorities and deliverables before we start.
This is a Paragraph Font
Companies &
brands sold
Commercial agreements
completed
Investors &
partners engaged
Gastrointestinal medicines
Antibiotic alternatives
Eye laser technology
GI biotech
Antibiotic alternatives
Preclinical biotech
Nasal drug delivery
Liver cell technology
Oncolytic immunotherapy
Consumer health
Diagnostic imaging
CBD & cannabinoid products
We have led international healthcare businesses ourselves. Today, we bring that experience to founders and management teams turning promising innovations into commercially successful companies.
We've led international healthcare businesses ourselves. Today, we bring that experience to founders and management teams turning promising innovations into commercially successful companies.
Pharmacist · Former Global Marketing Director · Strategy & Commercialisation

Pharmacist · Former Global Marketing Director · Strategy & Commercialisation
MD · MBA · Former Pharma Managing Director · Commercialisation, Investment & M&A

MD · MBA · Former Pharma Managing Director · Commercialization, Investment & M&A
We have led pharma businesses and supported life sciences founders. We help you prepare the strategy, numbers and story that investors and industry partners will challenge.
We have led pharma businesses and supported life sciences founders. We help you prepare the strategy, numbers and story that investors and industry partners will challenge.

Dato Guna Mahalingam
Managing Partner · Strategic Swiss Partners · Switzerland

Dato Guna Mahalingam
Managing Partner · Strategic Swiss Partners

Elena Sgaravatti
Founder & General Manager · PlantaRei Biotech · Italy

Sara Isbell
Co-Founder & CEO · Enabled Therapeutics

Sara Isbell
Co-Founder & CEO · Enabled Therapeutics · USA

Hans U. Baer, MD
CEO Bauchmedizin AG / Baermed · Switzerland

Sophian Abdul Rahman
CEO · Delightex / Mudo Labs · Singapore
Tell us where you are, what you want to achieve and what is getting in the way. We will explore where we can make a difference.
Tell us where you are, what you want to achieve and what is getting in the way. We will explore where we can make a difference.
We work with a limited number of companies each year.
If we engage, we commit fully.
We work with a limited number of companies each year.
If we engage, we commit fully.
Yes. You may need help with your strategy, your investment materials or finding suitable partners. We start with what you need and build on the work you’ve already done. You don’t have to go through the full Position, Package, Partner approach.
Yes. We offer defined projects and ongoing fractional CMO/CCO support. You gain senior commercial capacity with clear responsibilities, priorities and agreed deliverables.
Yes. Our Investment Readiness Roadmap reviews your strategy, positioning, financials and materials. You receive an assessment, a personal walkthrough and a 90-day action roadmap. Scope and fee are agreed before we start.
We research suitable parties, make selected approaches and introductions, and prepare and follow up conversations. We assess what is ready now and what needs strengthening. Funding and agreements depend on third-party decisions and are not guaranteed.
Yes. We work with family offices, investors and innovation programmes to help their companies strengthen commercial direction, business cases and readiness for customers, investment or partnerships.
Let’s talk about your company, where you want to go
and what would help you take the next step.
Let’s talk about your company, where you want to go
and what would help you take the next step.
A confidential first conversation with Coert and Karin. No obligation.
To ensure alignment, we ask you to complete a short qualification form.
If there is a strong fit, we will schedule a private discussion.
A confidential first conversation with Coert and Karin. No obligation.
To ensure alignment, we ask you to complete a short qualification form.
If there is a strong fit, we will schedule a private discussion.


Senz Life Sciences
A business unit of Senz Strategy Consulting.
Senz Life Sciences
A business unit of Senz Strategy Consulting.
LET'S CONNECT
[email protected] ↗
WhatsApp Karin ↗
The Netherlands · Malaysia